Abstract:Objective To evaluate and compare the antibody to hepatitis B virus (HBV) surface antigen (anti-HBs) response and the influent factors of revaccination of 4 kinds of hepatitis B vaccine (HepB) among firstly low-response adults.Methods A total of 11 590 adults who were 18-49 years old,never received HepB vaccination,without HBV infection history,HBs-Ag negative,and had been living at 3 towns of Zhangqiu county in Shandong province Ji'nan city for more than half a year,were selected in the study in July,2009.Self-designed questionnaire was used to select the basic information of the subjects.The subjects were divided into 4 groups by cluster sampling,and were vaccinated according to the "0-1-6"immune procedure with 10 μgHepB made by recombinant deoxyribonucleic acid techniques in Saccharomyces Cerevisiae (HepB-SC),10 μg HepB made by recombinant deoxyribonucleic acid techniques in Hansenula Polymorpha (HepB-HP),20 μg HepB-SC and 20 μg HepB made by recombinant dexyribonucleic acid techniques in Chinese hamster ovary cell (HepB-CHO),3 doses respectively.The adults who were low-response to the primary hepatitis B vaccination (10 mU/ml≤anti-HBs ＜ 100 mU/ml)were divided into four groups by cluster sampling.These groups were revaccinated with one-dose of above-mentioned four kinds of HepB respectively.Blood samples were drawn from each person one month after the revaccination.Anti-HBs was detected by chemiluminescence microparticle immunoassay and compared by the vaccine type.The influence factors about antibody response were also analyzed.Results Out of the 11 590 subjects,8592 adults had accepted the primary vaccination of hepatitis B and been collected the blood samples; among whom,1306 subjects showed low-response,at the rate of 15.20％A total of 1034 low-response subjects accepted secondary strengthened vaccination and were collected blood samples; 55.13％ of them showed anti-HBs seroconversion (anti-HBs ≥ 100 mU/ml ); while the seroeonversion rate in each group was 44.54％ (106/238) in 10 μg HepB-SC group,57.14％ (156/273)in 10 μg HepB-HP group,56.08％ (143/255) in 20 μg HepB-SC group and 61.57％ (165/268) in 20 μg HepB-CHO group,respectively.There was significant difference among the groups (X2=17.14,P ＜ 0.01 ).The rates of anti-HBs seroconversion were significantly higher in 10 μg HepB-HP and 20 μg HepB-CHO groups than it in 10 μg HepB-SC group ( X2 were 8.09 and 14.70 respectively,P ＜ 0.01 ).The geometric mean concentration (GMC) of anti-HBs was 178.24 mU/ml among the low-responders after one dose of revaccination.The GMC was 109.77,243.50,144.98 and 242.83 mU/ml in 10 μg HepB-SC group,10 μg HepB-HP group,20 μg HepB-SC group and 20 μg HepB-CHO group,respectively.There was significant difference among groups ( F =9.52,P ＜ 0.01 ).Conclusion Anti-HBs response could be strengthened effectively after one-dose of HepB revaccination among the low-response adults.Many factors like the vaccine typs could effect the immune effects to HepB.A better response could be achieved if the 20 μg HepB-CHO or 10 μg HepB-HP was used for revaccination.

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: a 5-year follow-up study.

[A Five-Year Observation on Efficacy of Revaccination in Children of Non-Response to Hepatitis B Vaccine].

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011

Hepatitis B Revaccination in Healthy Non-Responder Chinese Children: Five-Year Follow-Up of Immune Response and Immunologic Memory.

Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults

Revaccination of Non- and Low- Responders after a Standard Three Dose Hepatitis B Vaccine Schedule

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

[Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up]

Long-term Protection of Infants Against Hepatitis B by Neonatal Immunoprophylaxis Born from Mothers Infected with Hepatitis B Virus

Long-term Efficacy of Infant Hepatitis B Immunization Program

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

The Serum Anti-HBs Level among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.

The effects of booster vaccination of hepatitis B vaccine on anti-HBs negative children 11-15 years after primary vaccination

Assessment on Serological Survey of Antibody to Hepatitis B Virus Surface Antigen Response to Revaccination of 5μg Recombinant Hepatitis B Vaccine Derived from Yeast with Different Type, Different Dosage and Different Schedule among Low-response Infants

[Persistence follow-up of immune memory to hepatitis B vaccine among infants with non- and low-response to primary vaccination after revaccination with three doses].

Effects of hepatitis B vaccine boosters in different levels of epidemic areas on anti-HBs-negative children after primary vaccination

Long-Term Efficacy And Immune Memory Of Neonatal Recombinant Hepatitis B Vaccination In Adolescents Aged 13-14 Years

Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China